- Home
- WTI vs TERN Comparison
WTI vs TERN Comparison
Compare WTI & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTI
- TERN
- Stock Information
- Founded
- WTI 1983
- TERN 2017
- Country
- WTI United States
- TERN United States
- Employees
- WTI N/A
- TERN N/A
- Industry
- WTI Oil & Gas Production
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- WTI Energy
- TERN Health Care
- Exchange
- WTI Nasdaq
- TERN Nasdaq
- Market Cap
- WTI 257.9M
- TERN 298.1M
- IPO Year
- WTI 2005
- TERN 2021
- Fundamental
- Price
- WTI $1.47
- TERN $2.49
- Analyst Decision
- WTI Strong Buy
- TERN Buy
- Analyst Count
- WTI 1
- TERN 5
- Target Price
- WTI $7.80
- TERN $18.38
- AVG Volume (30 Days)
- WTI 1.0M
- TERN 1.0M
- Earning Date
- WTI 05-09-2025
- TERN 05-12-2025
- Dividend Yield
- WTI 2.73%
- TERN N/A
- EPS Growth
- WTI N/A
- TERN N/A
- EPS
- WTI N/A
- TERN N/A
- Revenue
- WTI $525,260,999.00
- TERN N/A
- Revenue This Year
- WTI $6.42
- TERN N/A
- Revenue Next Year
- WTI N/A
- TERN N/A
- P/E Ratio
- WTI N/A
- TERN N/A
- Revenue Growth
- WTI N/A
- TERN N/A
- 52 Week Low
- WTI $1.30
- TERN $2.46
- 52 Week High
- WTI $2.84
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- WTI 38.47
- TERN 25.94
- Support Level
- WTI $1.58
- TERN $3.07
- Resistance Level
- WTI $1.68
- TERN $3.72
- Average True Range (ATR)
- WTI 0.06
- TERN 0.22
- MACD
- WTI -0.01
- TERN -0.04
- Stochastic Oscillator
- WTI 17.31
- TERN 2.38
About WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.